On Wednesday the 20^th October we hosted an international webinar that examined PuraStat’s impact on patient care. The meeting was moderated by some of Europe’s leading experts in Gastroenterology including Professor Helmut Neumann, Professor Alessandro Repici and Professor Pradeep Bhandari.

PuraStat is rapidly becoming a popular tool for endoscopists across the world, due in no small part to its proven efficacy and simple ease of use. The clear ready mixed hydrogel offers consultants the ability to rapidly and observably achieve haemostasis in a safe and controlled manner without risk of perforation or charring of tissue. Owing to these factors PuraStat is now becoming widely adopted in a number of procedures such as EMR, ESD, ERCP and Radiation proctitis to name but a few.

The webinar itself covered some fascinating topics which are outlined below;

• Dr Roberta Maselli: Discussed PuraStat’s promising role of managing intraprocedural bleeding and protecting against delayed bleeding whilst also allowing for continuation of the procedure and further resection if needed.
• Dr Christian Bojarski: Shared his teams promising research into PuraStat’s potential ability to help treat primary bleeding. Data in this area is promising as a bridge to surgery (please note PS is currently off label for primary bleeding).
• Dr Sharmila Subramaniam: Shared the fantastic data which has been produced from the POPS study at Queen Alexandria Hospital in Portsmouth. Interesting points from this talk were to highlight that clipping isn’t always cost effective or technically easy to do and PuraStat offers an efficacious alternative. Furthermore in gastric resections where PuraStat was applied there were no reports of delayed bleeding.

If you wish to hear the full content of the webinar than please register your interest here: https://events.3dmatrix.com/pss21-oct-rec-form . Alternatively contact our partners Healthcare 21 for support or requests to trial PuraStat.